HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Piperazine Dihydrochloride → Irbesartan
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | Piperazine Dihydrochloride | HCID 8893 | — |
| Edukt | Sodium Azide | HCID 33557 | — |
| Edukt | 4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | HCID 9843116 | — |
| Lösungsmittel | O-Xylene | HCID 7237 | — |
| Produkt | Irbesartan | HCID 3749 | 96% |
Reaktionsschritte
A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08080670B2 |
| Quelldatensatz | uspto-grants-2011_12 |
| ORD ID | ord-a67296b3abe540c4a17ddd7e7fd19fb6 |
| Quellennotiz | uspto-grants-2011_12 |